hormone glp-1 drugs protect brain health by improving neurovascular function and reducing inflammation GLP-1 medications are getting a
Description
GLP-1 receptors exist in brain regions involved in attention and impulse control, but this does not establish clinical efficacy for ADHD
Alejandra de Torres has the following financial relationships: lectures for Novo-Nordisk, received grant support from Abbott, and research activities from Novo-Nordisk and Eli Lilly and Company
Orforglipron is in Phase 3 clinical trials now
It is sold in two forms Mounjaro and Zepbound by US pharmaceutical company Eli Lilly
Disposal of unused or expired medication should follow appropriate pharmaceutical waste disposal guidelines
